nodes	percent_of_prediction	percent_of_DWPC	metapath
Flavoxate—Raloxifene—osteoporosis	0.642	1	CrCtD
Flavoxate—Dyclonine—Raloxifene—osteoporosis	0.22	0.752	CrCrCtD
Flavoxate—Cloperastine—Raloxifene—osteoporosis	0.0725	0.248	CrCrCtD
Flavoxate—Raloxifene—ESR2—osteoporosis	0.000766	0.438	CrCbGaD
Flavoxate—Raloxifene—CYP19A1—osteoporosis	0.000513	0.293	CrCbGaD
Flavoxate—Confusional state—Calcium Acetate—osteoporosis	0.000482	0.0216	CcSEcCtD
Flavoxate—Raloxifene—ESR1—osteoporosis	0.000472	0.27	CrCbGaD
Flavoxate—Drowsiness—Calcitriol—osteoporosis	0.000399	0.0179	CcSEcCtD
Flavoxate—Feeling abnormal—Calcium Acetate—osteoporosis	0.000394	0.0177	CcSEcCtD
Flavoxate—Leukopenia—Etidronic acid—osteoporosis	0.000344	0.0154	CcSEcCtD
Flavoxate—Tension—Estropipate—osteoporosis	0.000326	0.0146	CcSEcCtD
Flavoxate—Nervousness—Estropipate—osteoporosis	0.000323	0.0145	CcSEcCtD
Flavoxate—Confusional state—Etidronic acid—osteoporosis	0.000316	0.0142	CcSEcCtD
Flavoxate—Vomiting—Calcium Acetate—osteoporosis	0.000304	0.0136	CcSEcCtD
Flavoxate—Vertigo—Estropipate—osteoporosis	0.000299	0.0134	CcSEcCtD
Flavoxate—Vertigo—Alendronate—osteoporosis	0.000294	0.0132	CcSEcCtD
Flavoxate—Palpitations—Estropipate—osteoporosis	0.000294	0.0132	CcSEcCtD
Flavoxate—Vertigo—Raloxifene—osteoporosis	0.000289	0.013	CcSEcCtD
Flavoxate—Vertigo—Ibandronate—osteoporosis	0.000286	0.0129	CcSEcCtD
Flavoxate—Nausea—Calcium Acetate—osteoporosis	0.000284	0.0127	CcSEcCtD
Flavoxate—Palpitations—Ibandronate—osteoporosis	0.000282	0.0126	CcSEcCtD
Flavoxate—Dry mouth—Ibandronate—osteoporosis	0.000265	0.0119	CcSEcCtD
Flavoxate—Skin disorder—Estropipate—osteoporosis	0.000263	0.0118	CcSEcCtD
Flavoxate—Dry mouth—Calcitriol—osteoporosis	0.00026	0.0117	CcSEcCtD
Flavoxate—Feeling abnormal—Etidronic acid—osteoporosis	0.000258	0.0116	CcSEcCtD
Flavoxate—Skin disorder—Raloxifene—osteoporosis	0.000255	0.0115	CcSEcCtD
Flavoxate—Skin disorder—Ibandronate—osteoporosis	0.000253	0.0113	CcSEcCtD
Flavoxate—Nausea—Ergocalciferol—osteoporosis	0.000251	0.0113	CcSEcCtD
Flavoxate—Urticaria—Etidronic acid—osteoporosis	0.000249	0.0112	CcSEcCtD
Flavoxate—Skin disorder—Calcitriol—osteoporosis	0.000247	0.0111	CcSEcCtD
Flavoxate—Tension—Pamidronate—osteoporosis	0.000245	0.011	CcSEcCtD
Flavoxate—Nervousness—Pamidronate—osteoporosis	0.000242	0.0109	CcSEcCtD
Flavoxate—Somnolence—Estropipate—osteoporosis	0.000241	0.0108	CcSEcCtD
Flavoxate—Vertigo—Risedronate—osteoporosis	0.000236	0.0106	CcSEcCtD
Flavoxate—Somnolence—Calcitriol—osteoporosis	0.000226	0.0102	CcSEcCtD
Flavoxate—Leukopenia—Pamidronate—osteoporosis	0.000223	0.01	CcSEcCtD
Flavoxate—Feeling abnormal—Alendronate—osteoporosis	0.00022	0.00988	CcSEcCtD
Flavoxate—Dry mouth—Risedronate—osteoporosis	0.000219	0.00982	CcSEcCtD
Flavoxate—Tension—Conjugated Estrogens—osteoporosis	0.000215	0.00968	CcSEcCtD
Flavoxate—Urticaria—Estropipate—osteoporosis	0.000215	0.00968	CcSEcCtD
Flavoxate—Vision blurred—Zoledronate—osteoporosis	0.000215	0.00965	CcSEcCtD
Flavoxate—Feeling abnormal—Ibandronate—osteoporosis	0.000214	0.00962	CcSEcCtD
Flavoxate—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000214	0.00959	CcSEcCtD
Flavoxate—Nervousness—Conjugated Estrogens—osteoporosis	0.000213	0.00958	CcSEcCtD
Flavoxate—Urticaria—Alendronate—osteoporosis	0.000212	0.00953	CcSEcCtD
Flavoxate—Skin disorder—Risedronate—osteoporosis	0.000208	0.00935	CcSEcCtD
Flavoxate—Vision blurred—Conjugated Estrogens—osteoporosis	0.000207	0.00929	CcSEcCtD
Flavoxate—Urticaria—Ibandronate—osteoporosis	0.000207	0.00928	CcSEcCtD
Flavoxate—Confusional state—Pamidronate—osteoporosis	0.000205	0.00923	CcSEcCtD
Flavoxate—Vertigo—Zoledronate—osteoporosis	0.000205	0.0092	CcSEcCtD
Flavoxate—Leukopenia—Zoledronate—osteoporosis	0.000204	0.00917	CcSEcCtD
Flavoxate—Urticaria—Calcitriol—osteoporosis	0.000202	0.00908	CcSEcCtD
Flavoxate—Palpitations—Zoledronate—osteoporosis	0.000202	0.00905	CcSEcCtD
Flavoxate—Vomiting—Etidronic acid—osteoporosis	0.000199	0.00895	CcSEcCtD
Flavoxate—Tachycardia—Pamidronate—osteoporosis	0.000199	0.00893	CcSEcCtD
Flavoxate—Vertigo—Conjugated Estrogens—osteoporosis	0.000197	0.00886	CcSEcCtD
Flavoxate—Headache—Etidronic acid—osteoporosis	0.000196	0.00882	CcSEcCtD
Flavoxate—Palpitations—Conjugated Estrogens—osteoporosis	0.000194	0.00871	CcSEcCtD
Flavoxate—Dry mouth—Zoledronate—osteoporosis	0.00019	0.00853	CcSEcCtD
Flavoxate—Confusional state—Zoledronate—osteoporosis	0.000188	0.00843	CcSEcCtD
Flavoxate—Nausea—Etidronic acid—osteoporosis	0.000186	0.00836	CcSEcCtD
Flavoxate—Tachycardia—Zoledronate—osteoporosis	0.000182	0.00816	CcSEcCtD
Flavoxate—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000181	0.00813	CcSEcCtD
Flavoxate—Somnolence—Pamidronate—osteoporosis	0.000181	0.00813	CcSEcCtD
Flavoxate—Skin disorder—Zoledronate—osteoporosis	0.000181	0.00812	CcSEcCtD
Flavoxate—Tachycardia—Conjugated Estrogens—osteoporosis	0.000175	0.00785	CcSEcCtD
Flavoxate—Urticaria—Ethinyl Estradiol—osteoporosis	0.000175	0.00784	CcSEcCtD
Flavoxate—Skin disorder—Conjugated Estrogens—osteoporosis	0.000174	0.00782	CcSEcCtD
Flavoxate—Tension—Estradiol—osteoporosis	0.000172	0.00774	CcSEcCtD
Flavoxate—Vomiting—Estropipate—osteoporosis	0.000172	0.00774	CcSEcCtD
Flavoxate—Nervousness—Estradiol—osteoporosis	0.000171	0.00766	CcSEcCtD
Flavoxate—Urticaria—Risedronate—osteoporosis	0.00017	0.00765	CcSEcCtD
Flavoxate—Headache—Estropipate—osteoporosis	0.00017	0.00763	CcSEcCtD
Flavoxate—Vomiting—Alendronate—osteoporosis	0.00017	0.00763	CcSEcCtD
Flavoxate—Feeling abnormal—Pamidronate—osteoporosis	0.000168	0.00754	CcSEcCtD
Flavoxate—Headache—Alendronate—osteoporosis	0.000167	0.00751	CcSEcCtD
Flavoxate—Vomiting—Raloxifene—osteoporosis	0.000167	0.0075	CcSEcCtD
Flavoxate—Somnolence—Zoledronate—osteoporosis	0.000165	0.00743	CcSEcCtD
Flavoxate—Vomiting—Ibandronate—osteoporosis	0.000165	0.00743	CcSEcCtD
Flavoxate—Headache—Raloxifene—osteoporosis	0.000165	0.00739	CcSEcCtD
Flavoxate—Headache—Ibandronate—osteoporosis	0.000163	0.00732	CcSEcCtD
Flavoxate—Vomiting—Calcitriol—osteoporosis	0.000162	0.00727	CcSEcCtD
Flavoxate—Nausea—Estropipate—osteoporosis	0.000161	0.00723	CcSEcCtD
Flavoxate—Headache—Calcitriol—osteoporosis	0.000159	0.00716	CcSEcCtD
Flavoxate—Somnolence—Conjugated Estrogens—osteoporosis	0.000159	0.00715	CcSEcCtD
Flavoxate—Nausea—Alendronate—osteoporosis	0.000159	0.00713	CcSEcCtD
Flavoxate—Vertigo—Estradiol—osteoporosis	0.000158	0.00709	CcSEcCtD
Flavoxate—Nausea—Raloxifene—osteoporosis	0.000156	0.00701	CcSEcCtD
Flavoxate—Palpitations—Estradiol—osteoporosis	0.000155	0.00697	CcSEcCtD
Flavoxate—Nausea—Ibandronate—osteoporosis	0.000154	0.00694	CcSEcCtD
Flavoxate—Feeling abnormal—Zoledronate—osteoporosis	0.000153	0.00689	CcSEcCtD
Flavoxate—Nausea—Calcitriol—osteoporosis	0.000151	0.00679	CcSEcCtD
Flavoxate—Urticaria—Zoledronate—osteoporosis	0.000148	0.00664	CcSEcCtD
Flavoxate—Dry mouth—Estradiol—osteoporosis	0.000146	0.00657	CcSEcCtD
Flavoxate—Confusional state—Estradiol—osteoporosis	0.000145	0.00649	CcSEcCtD
Flavoxate—Urticaria—Conjugated Estrogens—osteoporosis	0.000142	0.00639	CcSEcCtD
Flavoxate—Tachycardia—Estradiol—osteoporosis	0.00014	0.00629	CcSEcCtD
Flavoxate—Vomiting—Ethinyl Estradiol—osteoporosis	0.00014	0.00628	CcSEcCtD
Flavoxate—Skin disorder—Estradiol—osteoporosis	0.000139	0.00626	CcSEcCtD
Flavoxate—Headache—Ethinyl Estradiol—osteoporosis	0.000138	0.00618	CcSEcCtD
Flavoxate—Vomiting—Risedronate—osteoporosis	0.000136	0.00612	CcSEcCtD
Flavoxate—Headache—Risedronate—osteoporosis	0.000134	0.00603	CcSEcCtD
Flavoxate—Nausea—Ethinyl Estradiol—osteoporosis	0.000131	0.00586	CcSEcCtD
Flavoxate—Vomiting—Pamidronate—osteoporosis	0.00013	0.00582	CcSEcCtD
Flavoxate—Headache—Pamidronate—osteoporosis	0.000128	0.00573	CcSEcCtD
Flavoxate—Somnolence—Estradiol—osteoporosis	0.000128	0.00573	CcSEcCtD
Flavoxate—Nausea—Risedronate—osteoporosis	0.000127	0.00572	CcSEcCtD
Flavoxate—Nausea—Pamidronate—osteoporosis	0.000121	0.00543	CcSEcCtD
Flavoxate—Vomiting—Zoledronate—osteoporosis	0.000118	0.00531	CcSEcCtD
Flavoxate—Feeling abnormal—Estradiol—osteoporosis	0.000118	0.00531	CcSEcCtD
Flavoxate—Headache—Zoledronate—osteoporosis	0.000117	0.00524	CcSEcCtD
Flavoxate—Vomiting—Conjugated Estrogens—osteoporosis	0.000114	0.00512	CcSEcCtD
Flavoxate—Urticaria—Estradiol—osteoporosis	0.000114	0.00512	CcSEcCtD
Flavoxate—Headache—Conjugated Estrogens—osteoporosis	0.000112	0.00504	CcSEcCtD
Flavoxate—Nausea—Zoledronate—osteoporosis	0.000111	0.00496	CcSEcCtD
Flavoxate—Nausea—Conjugated Estrogens—osteoporosis	0.000106	0.00478	CcSEcCtD
Flavoxate—Vomiting—Estradiol—osteoporosis	9.12e-05	0.00409	CcSEcCtD
Flavoxate—Headache—Estradiol—osteoporosis	8.99e-05	0.00403	CcSEcCtD
Flavoxate—Nausea—Estradiol—osteoporosis	8.52e-05	0.00383	CcSEcCtD
Flavoxate—CHRM2—GPCR ligand binding—CALCA—osteoporosis	1.94e-05	0.000466	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—FGA—osteoporosis	1.92e-05	0.000462	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—SPP1—osteoporosis	1.91e-05	0.000459	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—PTH—osteoporosis	1.9e-05	0.000456	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—ADCY5—osteoporosis	1.9e-05	0.000455	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—WNT1—osteoporosis	1.88e-05	0.000452	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—RAP1A—osteoporosis	1.87e-05	0.000449	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—IRS2—osteoporosis	1.86e-05	0.000446	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CNR2—osteoporosis	1.85e-05	0.000445	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—ADCY5—osteoporosis	1.84e-05	0.000442	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—FGA—osteoporosis	1.83e-05	0.00044	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—NFATC1—osteoporosis	1.82e-05	0.000438	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—IRS1—osteoporosis	1.82e-05	0.000437	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—IRS1—osteoporosis	1.82e-05	0.000437	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—LEP—osteoporosis	1.82e-05	0.000437	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—CALCA—osteoporosis	1.81e-05	0.000434	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—DKK1—osteoporosis	1.81e-05	0.000434	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—ADCY5—osteoporosis	1.81e-05	0.000433	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—PTHLH—osteoporosis	1.79e-05	0.000429	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—BMP2—osteoporosis	1.79e-05	0.000429	CbGpPWpGaD
Flavoxate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	1.78e-05	0.000427	CbGpPWpGaD
Flavoxate—PDE4C—GPCR downstream signaling—POMC—osteoporosis	1.77e-05	0.000424	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—POMC—osteoporosis	1.75e-05	0.000421	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—POMC—osteoporosis	1.75e-05	0.000421	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—FGB—osteoporosis	1.75e-05	0.00042	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—WNT1—osteoporosis	1.74e-05	0.000418	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—ESR1—osteoporosis	1.74e-05	0.000417	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—IRS2—osteoporosis	1.73e-05	0.000415	CbGpPWpGaD
Flavoxate—CHRM2—SIDS Susceptibility Pathways—IL1B—osteoporosis	1.73e-05	0.000414	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—SOST—osteoporosis	1.72e-05	0.000413	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—IL6R—osteoporosis	1.71e-05	0.00041	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—IL6R—osteoporosis	1.71e-05	0.00041	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—PTHLH—osteoporosis	1.7e-05	0.000409	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—BMP2—osteoporosis	1.7e-05	0.000409	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—SOST—osteoporosis	1.7e-05	0.000407	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—FGA—osteoporosis	1.7e-05	0.000407	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—LEP—osteoporosis	1.69e-05	0.000406	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—PSMA2—osteoporosis	1.69e-05	0.000406	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—PSMA5—osteoporosis	1.69e-05	0.000406	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—IGF1—osteoporosis	1.69e-05	0.000405	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—IGF1—osteoporosis	1.69e-05	0.000405	CbGpPWpGaD
Flavoxate—CHRM2—G alpha (i) signalling events—POMC—osteoporosis	1.68e-05	0.000402	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—ADCY5—osteoporosis	1.67e-05	0.000401	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—FGB—osteoporosis	1.67e-05	0.0004	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—KL—osteoporosis	1.64e-05	0.000394	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—IRS1—osteoporosis	1.62e-05	0.000389	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—ESR1—osteoporosis	1.61e-05	0.000387	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—PSMA2—osteoporosis	1.61e-05	0.000386	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—PSMA5—osteoporosis	1.61e-05	0.000386	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—POMC—osteoporosis	1.6e-05	0.000385	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—PTHLH—osteoporosis	1.58e-05	0.000378	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—BMP2—osteoporosis	1.58e-05	0.000378	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CALCA—osteoporosis	1.58e-05	0.000378	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—IL6R—osteoporosis	1.56e-05	0.000375	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—POMC—osteoporosis	1.56e-05	0.000375	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CALCR—osteoporosis	1.56e-05	0.000373	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PTH1R—osteoporosis	1.56e-05	0.000373	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—FGB—osteoporosis	1.54e-05	0.00037	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—POMC—osteoporosis	1.54e-05	0.000369	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CALCR—osteoporosis	1.54e-05	0.000368	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PTH1R—osteoporosis	1.54e-05	0.000368	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—IL6R—osteoporosis	1.52e-05	0.000366	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—PTH—osteoporosis	1.52e-05	0.000365	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—IRS1—osteoporosis	1.51e-05	0.000362	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—IGF1—osteoporosis	1.5e-05	0.000361	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—PTH—osteoporosis	1.5e-05	0.000361	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CALCA—osteoporosis	1.5e-05	0.00036	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—PSMA5—osteoporosis	1.49e-05	0.000357	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—PSMA2—osteoporosis	1.49e-05	0.000357	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—CNR2—osteoporosis	1.48e-05	0.000356	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—CNR2—osteoporosis	1.46e-05	0.000352	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—POMC—osteoporosis	1.46e-05	0.000351	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—POMC—osteoporosis	1.45e-05	0.000349	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—KL—osteoporosis	1.43e-05	0.000343	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—IL6R—osteoporosis	1.42e-05	0.00034	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—IGF1—osteoporosis	1.4e-05	0.000335	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—POMC—osteoporosis	1.4e-05	0.000335	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CALCA—osteoporosis	1.39e-05	0.000333	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—PTH—osteoporosis	1.38e-05	0.000332	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—PTH—osteoporosis	1.37e-05	0.000328	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—KL—osteoporosis	1.36e-05	0.000327	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—IL6R—osteoporosis	1.36e-05	0.000327	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—POMC—osteoporosis	1.35e-05	0.000325	CbGpPWpGaD
Flavoxate—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	1.35e-05	0.000324	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—CNR2—osteoporosis	1.35e-05	0.000323	CbGpPWpGaD
Flavoxate—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	1.33e-05	0.00032	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—CNR2—osteoporosis	1.33e-05	0.000319	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—POMC—osteoporosis	1.33e-05	0.000319	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—IL6R—osteoporosis	1.3e-05	0.000311	CbGpPWpGaD
Flavoxate—PDE8B—Signaling by GPCR—IL6—osteoporosis	1.29e-05	0.00031	CbGpPWpGaD
Flavoxate—PDE8A—Signaling by GPCR—IL6—osteoporosis	1.29e-05	0.00031	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—ADCY5—osteoporosis	1.29e-05	0.000309	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—WNT1—osteoporosis	1.27e-05	0.000304	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—PTHLH—osteoporosis	1.26e-05	0.000303	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—KL—osteoporosis	1.26e-05	0.000302	CbGpPWpGaD
Flavoxate—CHRM2—SIDS Susceptibility Pathways—TNF—osteoporosis	1.25e-05	0.000301	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—WNT1—osteoporosis	1.25e-05	0.0003	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—PTHLH—osteoporosis	1.25e-05	0.000299	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—SPP1—osteoporosis	1.25e-05	0.000299	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—MGLL—osteoporosis	1.24e-05	0.000296	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—POMC—osteoporosis	1.23e-05	0.000295	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—MGLL—osteoporosis	1.22e-05	0.000293	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—LRP5—osteoporosis	1.21e-05	0.000289	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—IL6R—osteoporosis	1.2e-05	0.000288	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—LRP5—osteoporosis	1.19e-05	0.000286	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—LRP6—osteoporosis	1.15e-05	0.000277	CbGpPWpGaD
Flavoxate—PDE7B—Signaling by GPCR—IL6—osteoporosis	1.15e-05	0.000276	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—PTHLH—osteoporosis	1.15e-05	0.000275	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—LRP6—osteoporosis	1.14e-05	0.000273	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—PTHLH—osteoporosis	1.13e-05	0.000271	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—IRS2—osteoporosis	1.13e-05	0.00027	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—ADCY5—osteoporosis	1.12e-05	0.000269	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—CALCA—osteoporosis	1.11e-05	0.000267	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—LEP—osteoporosis	1.1e-05	0.000265	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—CALCA—osteoporosis	1.1e-05	0.000263	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—SPP1—osteoporosis	1.08e-05	0.00026	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—IL6—osteoporosis	1.07e-05	0.000256	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—ADCY5—osteoporosis	1.07e-05	0.000256	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—ESR1—osteoporosis	1.05e-05	0.000253	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—SPP1—osteoporosis	1.03e-05	0.000248	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—POMC—osteoporosis	1.03e-05	0.000247	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—POMC—osteoporosis	1.02e-05	0.000244	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—MYC—osteoporosis	1.01e-05	0.000243	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—MYC—osteoporosis	1.01e-05	0.000243	CbGpPWpGaD
Flavoxate—CHRM2—SIDS Susceptibility Pathways—IL6—osteoporosis	1.01e-05	0.000243	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—TGFB1—osteoporosis	1.01e-05	0.000243	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—TGFB1—osteoporosis	1.01e-05	0.000243	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—CALCA—osteoporosis	1.01e-05	0.000242	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—CALCA—osteoporosis	9.96e-06	0.000239	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—ADCY5—osteoporosis	9.87e-06	0.000237	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—IRS1—osteoporosis	9.83e-06	0.000236	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—IRS2—osteoporosis	9.81e-06	0.000235	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TLN1—osteoporosis	9.74e-06	0.000234	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TLN1—osteoporosis	9.61e-06	0.000231	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—LEP—osteoporosis	9.6e-06	0.00023	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—SPP1—osteoporosis	9.55e-06	0.000229	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—POMC—osteoporosis	9.47e-06	0.000227	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—IRS2—osteoporosis	9.33e-06	0.000224	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—IL6R—osteoporosis	9.24e-06	0.000222	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—ESR1—osteoporosis	9.16e-06	0.00022	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—LEP—osteoporosis	9.13e-06	0.000219	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—IGF1—osteoporosis	9.11e-06	0.000219	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—MYC—osteoporosis	9.03e-06	0.000217	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—TGFB1—osteoporosis	9.01e-06	0.000216	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—ESR1—osteoporosis	8.72e-06	0.000209	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—IRS2—osteoporosis	8.64e-06	0.000207	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—IRS1—osteoporosis	8.56e-06	0.000205	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—LEP—osteoporosis	8.45e-06	0.000203	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—MYC—osteoporosis	8.4e-06	0.000202	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—P4HB—osteoporosis	8.4e-06	0.000202	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—TGFB1—osteoporosis	8.38e-06	0.000201	CbGpPWpGaD
Flavoxate—CHRM1—Circadian rythm related genes—IL6—osteoporosis	8.36e-06	0.000201	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—P4HB—osteoporosis	8.29e-06	0.000199	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—POMC—osteoporosis	8.24e-06	0.000198	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PTH—osteoporosis	8.17e-06	0.000196	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—IRS1—osteoporosis	8.15e-06	0.000196	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—ESR1—osteoporosis	8.07e-06	0.000194	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PTH—osteoporosis	8.06e-06	0.000194	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—IL6R—osteoporosis	8.04e-06	0.000193	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—RAP1A—osteoporosis	8.03e-06	0.000193	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CNR2—osteoporosis	7.96e-06	0.000191	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—IGF1—osteoporosis	7.93e-06	0.00019	CbGpPWpGaD
Flavoxate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	7.93e-06	0.00019	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—RAP1A—osteoporosis	7.93e-06	0.00019	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—ADCY5—osteoporosis	7.9e-06	0.00019	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CNR2—osteoporosis	7.86e-06	0.000189	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—POMC—osteoporosis	7.85e-06	0.000188	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NFATC1—osteoporosis	7.83e-06	0.000188	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—ADCY5—osteoporosis	7.8e-06	0.000187	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—DKK1—osteoporosis	7.77e-06	0.000186	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NFATC1—osteoporosis	7.73e-06	0.000186	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—DKK1—osteoporosis	7.67e-06	0.000184	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—IL6R—osteoporosis	7.65e-06	0.000184	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—IL6—osteoporosis	7.62e-06	0.000183	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—IL6—osteoporosis	7.62e-06	0.000183	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—IGF1—osteoporosis	7.55e-06	0.000181	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—IRS1—osteoporosis	7.54e-06	0.000181	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—WNT1—osteoporosis	7.48e-06	0.00018	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—WNT1—osteoporosis	7.39e-06	0.000177	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—FGA—osteoporosis	7.28e-06	0.000175	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—POMC—osteoporosis	7.26e-06	0.000174	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—FGA—osteoporosis	7.19e-06	0.000172	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—ADCY5—osteoporosis	7.18e-06	0.000172	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—ADCY5—osteoporosis	7.08e-06	0.00017	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—IL6R—osteoporosis	7.08e-06	0.00017	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—IGF1—osteoporosis	6.98e-06	0.000168	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—IL6—osteoporosis	6.97e-06	0.000167	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—IL6—osteoporosis	6.79e-06	0.000163	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PTHLH—osteoporosis	6.77e-06	0.000162	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—BMP2—osteoporosis	6.77e-06	0.000162	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PTHLH—osteoporosis	6.68e-06	0.00016	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—BMP2—osteoporosis	6.68e-06	0.00016	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—FGB—osteoporosis	6.62e-06	0.000159	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—FGB—osteoporosis	6.54e-06	0.000157	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PSMA2—osteoporosis	6.39e-06	0.000153	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PSMA5—osteoporosis	6.39e-06	0.000153	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—IL6—osteoporosis	6.31e-06	0.000152	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PSMA5—osteoporosis	6.31e-06	0.000151	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PSMA2—osteoporosis	6.31e-06	0.000151	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—IL6—osteoporosis	6.06e-06	0.000146	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CALCA—osteoporosis	5.96e-06	0.000143	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CALCA—osteoporosis	5.88e-06	0.000141	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—POMC—osteoporosis	5.81e-06	0.000139	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—IL6—osteoporosis	5.77e-06	0.000138	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—POMC—osteoporosis	5.74e-06	0.000138	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—MYC—osteoporosis	5.47e-06	0.000131	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—TGFB1—osteoporosis	5.46e-06	0.000131	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—KL—osteoporosis	5.41e-06	0.00013	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—KL—osteoporosis	5.34e-06	0.000128	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—IL6—osteoporosis	5.34e-06	0.000128	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—POMC—osteoporosis	5.28e-06	0.000127	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—POMC—osteoporosis	5.21e-06	0.000125	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—IL6R—osteoporosis	5.15e-06	0.000124	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—IL6R—osteoporosis	5.08e-06	0.000122	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—MYC—osteoporosis	4.76e-06	0.000114	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—TGFB1—osteoporosis	4.75e-06	0.000114	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—MYC—osteoporosis	4.54e-06	0.000109	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—TGFB1—osteoporosis	4.52e-06	0.000109	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ADCY5—osteoporosis	4.24e-06	0.000102	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—MYC—osteoporosis	4.2e-06	0.000101	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—TGFB1—osteoporosis	4.19e-06	0.0001	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ADCY5—osteoporosis	4.18e-06	0.0001	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—IL6—osteoporosis	4.11e-06	9.87e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—SPP1—osteoporosis	4.1e-06	9.84e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—SPP1—osteoporosis	4.05e-06	9.71e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IRS2—osteoporosis	3.71e-06	8.9e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IRS2—osteoporosis	3.66e-06	8.79e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—LEP—osteoporosis	3.63e-06	8.71e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—LEP—osteoporosis	3.58e-06	8.6e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—IL6—osteoporosis	3.58e-06	8.6e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ESR1—osteoporosis	3.47e-06	8.32e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ESR1—osteoporosis	3.42e-06	8.21e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—IL6—osteoporosis	3.41e-06	8.18e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IRS1—osteoporosis	3.24e-06	7.77e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IRS1—osteoporosis	3.2e-06	7.67e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—IL6—osteoporosis	3.15e-06	7.57e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—POMC—osteoporosis	3.12e-06	7.48e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—POMC—osteoporosis	3.08e-06	7.39e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IL6R—osteoporosis	3.04e-06	7.3e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IL6R—osteoporosis	3e-06	7.2e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IGF1—osteoporosis	3e-06	7.2e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IGF1—osteoporosis	2.96e-06	7.1e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—IL6—osteoporosis	2.29e-06	5.5e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—IL6—osteoporosis	2.26e-06	5.43e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—MYC—osteoporosis	1.8e-06	4.33e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TGFB1—osteoporosis	1.8e-06	4.31e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—MYC—osteoporosis	1.78e-06	4.27e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TGFB1—osteoporosis	1.77e-06	4.26e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IL6—osteoporosis	1.35e-06	3.25e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IL6—osteoporosis	1.34e-06	3.21e-05	CbGpPWpGaD
